Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial
Authors
Keywords
-
Journal
Annals of Intensive Care
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-03-12
DOI
10.1186/s13613-023-01109-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-7 Immunotherapy in a Nonimmunocompromised Patient With Intractable Fungal Wound Sepsis
- (2021) Isaiah R Turnbull et al. Open Forum Infectious Diseases
- Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19)
- (2020) Pierre Francois Laterre et al. JAMA Network Open
- Flip the coin: IL-7 and IL-7R in health and disease
- (2019) João T. Barata et al. NATURE IMMUNOLOGY
- First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
- (2018) Rizwan Romee et al. BLOOD
- Administration of interleukin-7 increases CD4 T cells in idiopathic CD4 lymphocytopenia
- (2015) V. Sheikh et al. BLOOD
- Persistent Lymphopenia After Diagnosis of Sepsis Predicts Mortality
- (2014) Anne M. Drewry et al. SHOCK
- Treatment of Progressive Multifocal Leukoencephalopathy With Interleukin 7
- (2014) Karl B. Alstadhaug et al. JAMA Neurology
- Reduction of Immunocompetent T Cells Followed by Prolonged Lymphopenia in Severe Sepsis in the Elderly*
- (2013) Shigeaki Inoue et al. CRITICAL CARE MEDICINE
- Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation
- (2012) M.-A. Perales et al. BLOOD
- Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study
- (2012) Y. Lévy et al. CLINICAL INFECTIOUS DISEASES
- IL-7 Restores Lymphocyte Functions in Septic Patients
- (2012) F. Venet et al. JOURNAL OF IMMUNOLOGY
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
- (2011) Jonathan S. Boomer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A case of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia
- (2010) A. Patel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in Sepsis
- (2010) J. Unsinger et al. JOURNAL OF IMMUNOLOGY
- EARLY ASSESSMENT OF LEUKOCYTE ALTERATIONS AT DIAGNOSIS OF SEPTIC SHOCK
- (2010) Fabienne Venet et al. SHOCK
- Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques
- (2009) S. Beq et al. BLOOD
- Where have all the T cells gone?
- (2009) I. Sereti BLOOD
- IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection
- (2009) I. Sereti et al. BLOOD
- Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
- (2008) Claude Sportès et al. JOURNAL OF EXPERIMENTAL MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started